Stay updated on SGLT-2 Inhibitor in HF Hepato-Renal Clinical Trial
Sign up to get notified when there's something new on the SGLT-2 Inhibitor in HF Hepato-Renal Clinical Trial page.

Latest updates to the SGLT-2 Inhibitor in HF Hepato-Renal Clinical Trial page
- Check6 days agoChange DetectedNew revision v3.3.2 is added to the record history, replacing v3.3.1; this reflects a minor site update with no changes to study data or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check13 days agoChange DetectedNew revision added to the record history: Revision v3.3.1 has been posted, superseding the previous v3.2.0. This change only updates the version history and does not affect trial data or public content.SummaryDifference0.1%

- Check21 days agoChange DetectedThe government funding notice at the top of the page was removed, and the page now lacks that explicit status message. This change does not alter the clinical trial record history, study data, or navigational structure. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check35 days agoChange DetectedThe Record History page shows the same set of study record versions; the layout is slightly different but no new data or status changes are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange Detected- Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.SummaryDifference13%

- Check71 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.3%

Stay in the know with updates to SGLT-2 Inhibitor in HF Hepato-Renal Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SGLT-2 Inhibitor in HF Hepato-Renal Clinical Trial page.